Equine Healthcare Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Equine Healthcare Market

1.1. Definition and Scope

1.1.1. Definition of Equine Healthcare

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Equine Healthcare Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Equine Healthcare Market By Indication

1.2.3. Equine Healthcare Market By Product

1.2.4. Equine Healthcare Market By Distribution Channel

1.2.5. Equine Healthcare Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Equine Healthcare Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Equine Healthcare Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Equine Healthcare Market By Indication

5.1. Introduction

5.2. Equine Healthcare Revenue By Indication

5.2.1. Equine Healthcare Revenue (USD Billion) and Forecast, By Indication, 2020-2032

5.2.2. Musculoskeletal Disorders

5.2.2.1. Musculoskeletal Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Internal Medicine

5.2.3.1. Internal Medicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Parasite Control

5.2.4.1. Parasite Control Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Equine Influenza

5.2.5.1. Equine Influenza Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Equine Herpes Virus

5.2.6.1. Equine Herpes Virus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.7. West Nile Virus

5.2.7.1. West Nile Virus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.8. Tetanus

5.2.8.1. Tetanus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.9. Equine Encephalomyelitis

5.2.9.1. Equine Encephalomyelitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.10. Others

5.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Equine Healthcare Market By Product

6.1. Introduction

6.2. Equine Healthcare Revenue By Product

6.2.1. Equine Healthcare Revenue (USD Billion) and Forecast, By Product, 2020-2032

6.2.2. Vaccines

6.2.2.1. Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Pharmaceuticals

6.2.3.1. Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.2. Anti-infectives

6.2.3.2.1. Anti-infectives Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.3. Parasiticides

6.2.3.3.1. Parasiticides Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.4. Anti-inflammatory & Analgesics

6.2.3.4.1. Anti-inflammatory & Analgesics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.5. Other Pharmaceuticals

6.2.3.5.1. Other Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Diagnostics

6.2.4.1. Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Medicinal Feed Additives

6.2.5.1. Medicinal Feed Additives Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Software & Services

6.2.6.1. Software & Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7. Others

6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Equine Healthcare Market By Distribution Channel

7.1. Introduction

7.2. Equine Healthcare Revenue By Distribution Channel

7.2.1. Equine Healthcare Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032

7.2.2. Veterinary Hospitals & Clinics

7.2.2.1. Veterinary Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. E-commerce

7.2.3.1. E-commerce Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Others

7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Equine Healthcare Market By Country 

8.1. North America Equine Healthcare Market Overview

8.2. U.S.

8.2.1. U.S. Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

8.2.2. U.S. Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

8.2.3. U.S. Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.3. Canada

8.3.1. Canada Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

8.3.2. Canada Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

8.3.3. Canada Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Equine Healthcare Market By Country

9.1. Europe Equine Healthcare Market Overview

9.2. U.K.

9.2.1. U.K. Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.2.2. U.K. Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

9.2.3. U.K. Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.3. Germany

9.3.1. Germany Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.3.2. Germany Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

9.3.3. Germany Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.4. France

9.4.1. France Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.4.2. France Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

9.4.3. France Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.5. Spain

9.5.1. Spain Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.5.2. Spain Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

9.5.3. Spain Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.6.2. Rest of Europe Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

9.6.3. Rest of Europe Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Equine Healthcare Market By Country

10.1. Asia Pacific Equine Healthcare Market Overview

10.2. China

10.2.1. China Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.2.2. China Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

10.2.3. China Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.3. Japan

10.3.1. Japan Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.3.2. Japan Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

10.3.3. Japan Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.4. India

10.4.1. India Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.4.2. India Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

10.4.3. India Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.5. Australia

10.5.1. Australia Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.5.2. Australia Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

10.5.3. Australia Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.6. South Korea

10.6.1. South Korea Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.6.2. South Korea Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

10.6.3. South Korea Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.7.2. Rest of Asia-Pacific Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

10.7.3. Rest of Asia-Pacific Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Equine Healthcare Market By Country

11.1. Latin America Equine Healthcare Market Overview

11.2. Brazil

11.2.1. Brazil Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.2.2. Brazil Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

11.2.3. Brazil Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.3. Mexico

11.3.1. Mexico Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.3.2. Mexico Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

11.3.3. Mexico Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.4.2. Rest of Latin America Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

11.4.3. Rest of Latin America Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Equine Healthcare Market By Country 

12.1. Middle East & Africa Equine Healthcare Market Overview

12.2. GCC

12.2.1. GCC Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.2.2. GCC Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

12.2.3. GCC Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.3. South Africa

12.3.1. South Africa Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.3.2. South Africa Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

12.3.3. South Africa Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.4.2. Rest of Middle East & Africa Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032

12.4.3. Rest of Middle East & Africa Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Equine Healthcare Market

13.1. Equine Healthcare Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Equine Healthcare Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Zoetis Inc.

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2022

14.1.3.2. Zoetis Inc. 2022 Equine Healthcare Business Regional Distribution

14.1.4. Product/Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Merck & Co., Inc. (Animal Health Division)

14.3. Boehringer Ingelheim Animal Health

14.4. Elanco Animal Health

14.5. IDEXX Laboratories, Inc.

14.6. Dechra Pharmaceuticals PLC

14.7. CevaSantéAnimale

14.8. Vetoquinol S.A.

14.9. Norbrook Laboratories Ltd.

14.10. Neogen Corporation

14.11. Virbac Group

14.12. Heska Corporation